Suppr超能文献

中国肝细胞癌中肿瘤抑制基因的改变及等位基因缺失

Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.

作者信息

Fujimoto Y, Hampton L L, Wirth P J, Wang N J, Xie J P, Thorgeirsson S S

机构信息

Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

Cancer Res. 1994 Jan 1;54(1):281-5.

PMID:7903205
Abstract

Aflatoxin B1 has been suggested as a causative agent for a G to T mutation at codon 249 in the p53 gene in human hepatocellular carcinomas (HCC) from southern Africa and Qidong in China. The objective of the present work was to test the hypothesis that exposure to aflatoxin B1 either alone or coincident with other environmental carcinogens might be associated with allelic losses occurring during development of human hepatocarcinogenesis in China. The HCCs were obtained from two different areas in China: Qidong, where exposure to hepatitis B virus (HBV) and aflatoxin B1 is high; and Beijing, where exposure to HBV is high but that of aflatoxin B1 is low. We analyzed the tumors for mutations in the p53 gene and loss of heterozygosity for the p53, Rb, and APC genes and at marker loci on chromosomes 4, 13, and 16. Frequencies of mutation, loss, and aberration (mutation and loss) of the p53 gene in 25 HCCs from Qidong were 60, 58, and 80%, respectively. The frequencies in 9 HCCs from Beijing were 56, 57, and 78%. However, the frequency of a G to T transversion at codon 249 in HCCs from Qidong and Beijing were 52 and 0%, respectively. These data indicate that mutation and/or loss of heterozygosity in the p53 gene, independent of the 249 mutation, play a critical role in the development of hepatitis B virus-associated HCCs in China. Loss of the Rb and APC genes was observed in 44 and 7% of HCCs from Qidong, respectively. Allelic losses on chromosome 4 and especially on chromosome 16 were frequent in HCCs from Qidong but were not observed in HCCs from Beijing, while loss of heterozygosity on chromosome 13 occurred at similar frequency in both Qidong and Beijing. These results show a distinct difference in the pattern of allelic losses between HCCs in Qidong and Beijing and suggest that aflatoxin B1 and/or other environmental carcinogens may contribute to this difference.

摘要

黄曲霉毒素B1被认为是导致非洲南部和中国启东的人类肝细胞癌(HCC)中p53基因第249密码子发生G到T突变的致病因素。本研究的目的是检验以下假设:单独接触黄曲霉毒素B1或与其他环境致癌物同时接触,可能与中国人类肝癌发生过程中出现的等位基因缺失有关。这些肝细胞癌取自中国两个不同地区:启东,那里乙肝病毒(HBV)和黄曲霉毒素B1的暴露水平较高;以及北京,那里HBV暴露水平较高但黄曲霉毒素B1暴露水平较低。我们分析了肿瘤中p53基因的突变以及p53、Rb和APC基因及4号、13号和16号染色体上标记位点的杂合性缺失情况。启东的25例肝细胞癌中,p53基因的突变、缺失及畸变(突变和缺失)频率分别为60%、58%和80%。北京的9例肝细胞癌中的相应频率分别为56%、57%和78%。然而,启东和北京的肝细胞癌中第249密码子G到T颠换的频率分别为52%和0%。这些数据表明,p53基因的突变和/或杂合性缺失,与249位突变无关,在中国乙肝病毒相关肝细胞癌的发生中起关键作用。启东的肝细胞癌中分别有44%和7%观察到Rb和APC基因的缺失。4号染色体尤其是16号染色体上的等位基因缺失在启东的肝细胞癌中很常见,但在北京的肝细胞癌中未观察到,而13号染色体上的杂合性缺失在启东和北京的肝细胞癌中发生频率相似。这些结果显示启东和北京的肝细胞癌在等位基因缺失模式上存在明显差异,并表明黄曲霉毒素B1和/或其他环境致癌物可能导致了这种差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验